These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29587717)

  • 21. Metabolic syndrome in schizophrenia - who is more to blame: FGA polypharmacy or clozapine monotherapy?
    Softic R; Sutovic A; Avdibegovic E; Osmanović E; Bećirović E; Hajdukov MM
    Psychiatr Danub; 2015 Dec; 27(4):378-84. PubMed ID: 26609650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Treatment with Olanzapine in Hospital Conditions: Prevalence and Predictors of the Metabolic Syndrome.
    Popović I; Ravanić D; Janković S; Milovanović D; Folić M; Stanojević A; Nenadović M; Ilić M
    Srp Arh Celok Lek; 2015; 143(11-12):712-8. PubMed ID: 26946767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study.
    Bressington D; Mui J; Tse ML; Gray R; Cheung EF; Chien WT
    BMC Psychiatry; 2016 Nov; 16(1):411. PubMed ID: 27863522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
    Bener A; Al-Hamaq AO; Dafeeah EE
    Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Retrospective Chart Review of Screening on the Prevalence of Metabolic Syndrome (MetS) in an Irish Community Mental Health Service.
    Cocoman AM; Gallagher D
    Issues Ment Health Nurs; 2019 Oct; 40(10):895-901. PubMed ID: 31295053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study.
    Chue P; Mandel FS; Therrien F
    Curr Med Res Opin; 2014 Jun; 30(6):997-1005. PubMed ID: 24568177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
    Pallava A; Chadda RK; Sood M; Lakshmy R
    Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is abnormal non-high-density lipoprotein cholesterol a gender-specific predictor for metabolic syndrome in patients with schizophrenia taking second-generation antipsychotics?
    Lin EC; Shao WC; Yang HJ; Yen M; Lee SY; Wu PC; Lu RB
    Metab Brain Dis; 2015 Feb; 30(1):107-13. PubMed ID: 25034455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end products among patients maintained on antipsychotics.
    Hammoudeh S; Ghuloum S; Mahfoud Z; Yehya A; Mook-Kanamori D; Mook-Kanamori M; Suhre K; Abdulhakam A; Al-Mujalli A; Hani Y; El Sherbiny R; Al-Amin H
    Int Clin Psychopharmacol; 2017 Sep; 32(5):256-261. PubMed ID: 28492411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.
    Salvi V; Barone-Adesi F; D'Ambrosio V; Albert U; Maina G
    Psychopharmacology (Berl); 2016 Jan; 233(1):49-56. PubMed ID: 26407602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When Military Fitness Standards No Longer Apply: The High Prevalence of Metabolic Syndrome in Recent Air Force Retirees.
    Cranston MM; True MW; Wardian JL; Carriere RM; Sauerwein TJ
    Mil Med; 2017 Jul; 182(7):e1780-e1786. PubMed ID: 28810972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very low rates of screening for metabolic syndrome among patients with severe mental illness in Durban, South Africa.
    Saloojee S; Burns JK; Motala AA
    BMC Psychiatry; 2014 Aug; 14():228. PubMed ID: 25113131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care.
    Mundet-Tudurí X; Iglesias-Rodal M; Olmos-Domínguez C; Bernard-Antoranz ML; Fernández-San Martín MI; Amado-Guirado E
    Rev Neurol; 2013 Dec; 57(11):495-503. PubMed ID: 24265143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of melatonin in reducing second-generation antipsychotic metabolic effects: A double blind controlled clinical trial.
    Agahi M; Akasheh N; Ahmadvand A; Akbari H; Izadpanah F
    Diabetes Metab Syndr; 2018; 12(1):9-15. PubMed ID: 28847468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome and parental history of cardiovascular disease in young adults in urban Ghana.
    Yeboah K; Dodam KK; Affrim PK; Adu-Gyamfi L; Bado AR; Owusu Mensah RNA; Adjei AB; Gyan B
    BMC Public Health; 2017 Aug; 18(1):96. PubMed ID: 28774298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of metabolic syndrome in a middle-aged and elderly population with prehypertension in Tianjin.
    Yao W; Sun Y; Wang X; Si Q; Chen H; Wan Z
    Clin Exp Hypertens; 2015; 37(5):369-74. PubMed ID: 25496289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability.
    Pinhas-Hamiel O; Livne M; Harari G; Achiron A
    Eur J Neurol; 2015 Sep; 22(9):1275-9. PubMed ID: 25973530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
    Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.